Moreover, the anti‐depressant activity of n‐3 PUFAs is mediated by inhibition of TLR4, suggesting n‐3 PUFAs or TLR4 control may be a therapeutic strategy for depression. This evidence concerns the gene TLR4 and depressive symptom measurement.